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Herein, a simple label-free biosensor fabrication method is demonstrated based on transmission
localized surface plasmon resonance T-LSPR. The platform, which consists of a silver
nanoparticle array, can be prepared in just a few minutes using benchtop chemistry. The array was
made by a templating technique in conjunction with the photoreduction of Ag ions from solution.
This metal surface was functionalized with biotin-linked thiol ligands for binding streptavidin
molecules from solution. For an array of 19 nm diameter silver nanoparticles, a redshift in the
T-LSPR spectrum of 24 nm was observed upon protein-ligand binding at saturation. The binding
constant was found to be 21012 M−1. Platforms were also fabricated with silver nanoparticles of
34, 55, and 72 nm diameters. The maximum LSPR wavelength shift was nanoparticle size
dependent and the maximum sensitivity was obtained with the smaller nanoparticles. © 2009
American Vacuum Society. DOI: 10.1116/1.3284738
I. INTRODUCTION
Surface plasmon resonance SPR techniques have re-
cently become popular methods for designing chemical and
biological sensors because they afford label-free detection
with relatively highly sensitivity.1–5 Classical SPR applica-
tions exploit refractive index changes in the sensor/ﬂuid in-
terface to detect analyte molecules.6–10 The typical reﬂecto-
metry setup, however, somewhat limits the widespread
employment of this type of platform. Recently, a simpler
setup, transmission localized surface plasmon resonance, has
been demonstrated.11–16 Transmission localized surface plas-
mon resonance T-LSPR can be achieved with noble metal
nanoparticles spread on a transparent substrate. The nanopar-
ticle surface conduction electrons collectively oscillate when
an electromagnetic wave is introduced. This coherent oscil-
lation can induce photon absorption and scattering, both of
which are very sensitive to the dielectric properties of the
surrounding medium.15,17 This effect is typically present only
when the metal particle size is smaller than the wavelength
of the incident light. Moreover, this optical phenomenon is
strongly sensitive to nanoparticle size, shape, and
composition.18–20
In previous T-LSPR work, Okamoto et al.11 used colloidal
gold nanoparticles spread on glass substrates for sensing
polymer coatings. Rubinstein and co-workers12,21–23 demon-
strated the use of evaporated gold island ﬁlms for chemical
sensing. Malinsky et al.13 employed silver nanotriangles fab-
ricated by nanosphere lithography for sensing proteins.
Chilkoti and co-workers14,24–26 demonstrated successful col-
loidal gold nanoparticle and nanorod transmission T-LSPR
biosensors, while Dahlin et al.,27 Sharpe et al.,28 and Brolo
et al.29,30 utilized nanohole features as biosensing arrays.
Other researchers also employed similar transmission ap-
proaches for mono-/multilayer ﬁlm sensing.11,12,21–23 This in-
cludes protein binding assays,13,14,17,18,31 DNA hybridization
assays,32,33 as well as polymer studies.34
Because a conventional UV-visible spectrometer can be
employed with the T-LSPR approach, biosensing becomes
more convenient. Nevertheless, the fabrication of the sensing
platforms itself can still be an elaborate and time-consuming
process. Therefore, there is signiﬁcant impetus to designing a
simple, inexpensive, and rapid method for creating metal
nanoparticles arrays, which could maintain high sensitivity
for the detection of biomolecules.
We have recently demonstrated a rapid prototyping ap-
proach for the fabrication of nearly monodisperse silver
nanoparticle arrays on TiO2 thin ﬁlms.35 TiO2 is a well-
studied photocatalyst, which has been widely used for metal
nanoparticle preparation.36–43 The process involves the pho-
toreduction of metal ions by UV illumination of the oxide
thin ﬁlm.36,37,41–44 The size, shape, and density of the metal
nanoparticles in these studies could be well controlled by
using nanoporous alumina ﬁltration membranes as templates.
The alumina template conﬁned the size and shape of the
nanoparticles during their production. The entire fabrication
process could be completed rapidly at a standard benchtop
without the need for vacuum techniques or a clean-room en-
vironment. Moreover, metal particles in the size range of
10–100 nm could be easily produced using this technique.
We reasoned that our metal nanoparticle arrays should be
a convenient platform for creating T-LSPR biosensor sub-
strates Fig. 1. To investigate this, a monodisperse silver
nanoparticle array was fabricated by the templated photore-
duction process and then treated with a ligand-linked thiol
for protein capture from solution. The well-studied biotin/
streptavidin binding pair was chosen for this purpose. It was
found that the size of the silver nanoparticles employed was
critical for obtaining high quality binding data. Speciﬁcally,
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smaller particles 19 or 34 nm, which exhibited narrower
plasmon bands, were found to be superior to larger particles
50 nm. The platforms that were employed have some of
the narrowest size distributions for particle arrays used to
date for protein detection. The results clearly demonstrated
that excellent sensitivity from a single layer of metal par-
ticles could be achieved. In fact, quantitative equilibrium dis-
sociation constant data could also be abstracted.
II. EXPERIMENTAL SECTION
A. Materials
Polished Pyrex 7740 wafers 25.4 mm2 and 0.5 mm
thick were purchased from Precision Glass and Optics
Santa Ana, CA and nanoporous alumina ﬁltration mem-
brane templates came from Synkera Technologies
Longmont, CO. The nanotemplates had pore sizes of 18,
35, 55, and 73 nm 1.3 cm diameter and 50 m thickness.
The templates had pore densities of 51010, 11010,
5109, and 4109 pores /cm2, respectively, according to
the manufacturer. We conﬁrmed these values in house by
scanning electron microscopy Zeiss 1530 VP FE-SEM. Ti-
tanium IV isopropoxide, AgNO3, 4-2-hydroxyethyl
piperazine-1-ethane sulfonic acid HEPES buffer salt, bo-
vine serum albumin BSA, sodium phosphate, and sodium
chloride were purchased from Sigma-Aldrich Milwaukee,
WI. HCl was purchased from EM Industries Gibbstown,
NJ and isopropanol was purchased from Acros Geel,
Belgium. Ethanol was obtained from AAPER Alcohol and
Chemical Co. Shelbyville, KY. Puriﬁed water
18.2 M cm was prepared with a NANOpure Ultrapure
Water System Barnstead, Dubuque, IA. H2O2 and H2SO4
were purchased from EMD Chemicals Inc. Gibbstown, NJ.
Biotin polyethylene glycol PEG disulﬁde structure 1
and PEG propionate disulﬁde structure 2 were obtained
from BioVectra Inc. Prince Edward Island, Canada. Al-
though drawn in the protonated state, it should be noted that
structure 2 will lead to a net negative charge at the aqueous/
nanoparticle interface under the conditions of our experi-
ments. Streptavidin and Texas Red-labeled streptavidin were
purchased from Invitrogen Eugene, OR.




















HEPES buffer solution was made with puriﬁed water 10
mM, pH 7.4, while 10 mM phosphate buffered saline
PBS was prepared with puriﬁed water at pH 7.2. Biotin
PEG disulﬁde and PEG propionate disulﬁde solutions were
made as 2 and 10 mg/ml stock solutions in HEPES buffer,
respectively. These solutions were prepared immediately be-
fore use. The streptavidin, Texas Red-labeled streptavidin,
and BSA solutions were prepared in PBS buffer as stock
solutions at 1 mg/ml before dilution to the appropriate
concentration.
C. Preparation of biosensor substrates
A transparent Pyrex wafer was used as the substrate and
was cleaned in piranha solution 1:3 ratio of 30% H2O2 and
H2SO4 to remove organic contaminants from the surface.
Caution: piranha solution is a vigorous oxidant and should be
used with extreme care. Next, the substrate was rinsed with
copious amounts of puriﬁed water and dried with nitrogen
gas. At this point, 150 l of a TiO2 precursor solution was
deposited onto the surface of the slide with a pipette. This
solution was made from 1 g of titanium IV isopropoxide,
0.15 g of concentrated 37% HCl, and 8.0 g of isopropanol.
Next, a nanoporous alumina ﬁltration membrane was placed
on top of the solution-covered Pyrex slide and the liquid was
allowed to evaporate under ambient conditions for 6 min.
Following this, 300 l of 0.1 M AgNO3 solution was im-
mediately introduced to the top side of the alumina mem-
brane and the entire system was exposed to UV irradiation,
which was applied through the Pyrex side for 5 min. This
was done with a standard 500 W mercury arc lamp Newport
Oriel Instruments, Stratford, CT. After photoreduction in the
metal particles onto the TiO2 thin ﬁlm, the alumina template
was gently peeled away and the supported silver nanoparticle
FIG. 1. Color online Schematic of the process for fabricating monodisperse
silver nanoparticle based T-LSPR biosensors. a Silver nanoparticle array
templated by an alumina membrane on a thin TiO2 ﬁlm during the photore-
duction process. b Monodisperse silver nanoparticle array after alumina
membrane lift off. c Biotin/PEG modiﬁed silver nanoparticle biosensing
array. d Binding of streptavidin molecules.
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array was washed with ethanol and puriﬁed water. The entire
preparation procedure took 11 min to perform.
Once the sensor platform was formed, it was immediately
incubated in a solution containing 0.5 mg/ml biotin PEG
disulﬁde and 5.0 mg/ml PEG propionate disulﬁde 10 mM
HEPES, pH 7.4 for several hours.43 The PEG was em-
ployed to passivate nonspeciﬁc adsorption sites on the sensor
surface. To prevent oxidation of the biotin molecules, the
incubation was performed in the dark and the solution was
surrounded by a N2 atmosphere. This also helped prevent
oxidation of the Ag nanoparticles. Finally, the nanosensor
array was washed with ethanol and distilled water. At this
point it was ready for protein biosensing.
Fluorescence control experiments were performed to en-
sure that biotin was appropriately presented on the nanopar-
ticle array. A 1.0 M solution of Texas Red-labeled strepta-
vidin was introduced above the sample, incubated for 30
min, and then washed away with HEPES buffer. A strong
ﬂuorescent signal was detected from the sensing platform
under an upright ﬂuorescence microscope Eclipse E800,
Nikon. The ﬂuorescence response was almost completely
absent when a similar system was placed under a ﬂuores-
cence microscope without the presence of biotin ligands at
the interface.
D. SPR measurements and substrate imaging
Atomic force microscopy AFM measurements of Ag
nanoparticle arrays were made with a Nanoscope IIIa from
Digital Instruments Santa Barbara, CA. These experiments
were done in tapping mode in air with a type E scanner
employing etched silicon tips NSC15/No Al, Mikro Masch,
Wilsonville, OR. UV-visible spectra were taken with a
Lambda 35 UV/visible spectrometer PerkinElmer Instru-
ments, Shelton, CT. Since the Pyrex substrates were trans-
parent, the chips could be directly and conveniently seated
inside the spectrometer.
III. RESULTS
A. T-LSPR spectra of monodisperse Ag nanoparticle
arrays
In a ﬁrst set of experiments, a silver nanoparticle array
was prepared with an alumina membrane template contain-
ing 18 nm pores. These pores were roughly hexagonally ar-
rayed. The half sphere-shaped nanoparticles were quite uni-
form and had an average full width at half height FWHH at
their base of 193 nm according to AFM measurements
in agreement with previous studies data not shown.35 The
nearly monodisperse supported particle array was then tested
for T-LSPR. The absorption peak at 480 nm in the UV-
visible spectrum Fig. 2b is consistent with the plasmon
resonance of Ag nanoparticles reported in literature.44–46 It
suggests that the SPR properties of the Ag nanoparticles are
not signiﬁcantly changed by the TiO2 substrate. It should
also be noted that bare TiO2 surfaces had no such absorption
feature in this frequency range Fig. 2a.
Arrays with silver nanoparticles of different sizes were
fabricated by using nanoporous alumina templates with dif-
ferent pore sizes 35, 55, and 73 nm. AFM data for these
arrays looked essentially identical to those found previously
by employing this templating method.35 The silver nanopar-
ticles that were produced had average particle sizes FWHH
of 343, 556, and 727 nm, respectively. The plasmon
resonance absorption peak was found to redshift with in-
creasing size of the Ag nanoparticles Fig. 2. Moreover, the
peak intensity increased and the peak width broadened with
increasing particle size. Such observations are consistent
with theory.47–49 Indeed, the redshift of the absorption with
increasing nanoparticle size is thought to be a quantum con-
ﬁnement effect. Both the dipole and quadrupole resonance
modes should contribute to the peak and the resonance of the
quadrupole moment should appear at shorter wavelength
than that of the dipole moment.50,51 Moreover, the contribu-
tion from the quadrupole resonance modes increases with the
size of the nanoparticles. This is a signiﬁcant factor in the
peak broadening.50–54 Here we demonstrated that such spec-
tral properties can be achieved with nanoparticles made by a
very simple rapid prototyping method. In fact, the optical
properties appear to be comparable to, if not better than,
those obtained with metal particles which were fabricated by
more complex, expensive, and time-consuming processes.
B. T-LSPR biosensors
The monodisperse Ag nanoparticle array was incubated
for several hours in a solution containing 0.5 mg/ml biotin
PEG disulﬁde and 5 mg/ml PEG propionate disulﬁde in 10
mM HEPES buffer pH 7.4 to obtain a biotin terminated
surface, as shown schematically in Fig. 1c. This represents
a nominal ratio of biotin in background PEG of 1:10. The
modiﬁed nanoparticle array was then incubated with strepta-
FIG. 2. UV/visible spectra of a a bare TiO2 background and four different
diameter silver nanoparticle arrays fabricated by b 18 nm, c 35 nm, d
55 nm, and e 73 nm templates, respectively.
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vidin solutions of varying concentrations for 30 min. Absorp-
tion spectra were taken before and after incubation. Figure 3
shows representative experiments performed with a 19 nm
silver nanoparticle array. It was found that the plasmon band
redshifted upon protein adsorption until the surface was satu-
rated with protein. We also noted in most experiments that
the plasmon peak intensity increased upon adsorption; how-
ever, the peak intensity was not as reliable an indicator of
protein binding as the frequency shift, in agreement with
previous studies.31
Figure 4 shows the associate shift in peak frequency for
the plasmon band as a function of streptavidin concentration
for the 19 nm diameter Ag nanoparticles. Data were taken in
a protein concentration range from 10−16 M to 10−6 M. In
order to achieve equilibrium, all the protein incubation ex-
periments were performed in a dark, hermetically sealed en-
vironment for a minimum of 3 h.22 At the lowest protein
concentration 10−16 M, the solution was incubated for 24 h
to ensure equilibrium binding had been achieved. As can be
seen from the data, the plasmon resonance shifted with in-
creasing protein concentration and a simple Langmuir iso-
therm could be used to ﬁt the data,31
	/	max = KSA/1 + KSA ,
where 	 is the wavelength shift caused by the addition of
protein and 	max is the wavelength shift which was ob-
served at saturation. K is the apparent equilibrium associa-
tion constant and SA is the concentration of streptavidin
applied to the system. Using this equation gave a ﬁtted value
of K=21012 M−1, which is in rough agreement, although
slightly weaker than literature data for similar systems mea-
sured by complementary methods Green and Campbell:
1013 M−1, Chilkoti and Stayton: 2.51013 M−1.55–60 In
the present case, the binding constant is probably somewhat
weakened because the negatively charged surface slightly
destabilizes the bound state of the negatively charged strepta-
vidin molecules.
Several control experiments were run to ensure that the
data in Fig. 4 were not the result of nonspeciﬁc adsorption.
First, 1 mg/ml BSA in PBS buffer 10 mM PBS, pH 7.2
was introduced to the biotin-PEG-conjugated 19 nm silver
nanoparticle array. Very little, if any, discernable SPR peak
shift was observed under these conditions
	=1.01.0 nm, three trials. In a second control experi-
ment, a 5 mg/ml PEG propionate disulﬁde solution was in-
cubated over a Ag nanoparticle array in the absence of bioti-
nylated ligands. This system was challenged with a 10−6 M
streptavidin solution for 30 min. Again, little evidence for a
SPR shift could be found within experimental error
	=0.01.0 nm, three trials. Therefore, as expected,
nonspeciﬁc binding of protein molecules on the PEG-
covered nanoparticles was found to be quite low.43
By applying the same preparation methods, different di-
ameter silver nanoparticle biosensors were also examined.
Signiﬁcantly, the sensitivity of the sliver nanoparticle sensors
was particle size dependent. Figure 5 shows the absorption
spectra of silver nanoparticle biosensors prepared by the
same procedures as the 19 nm Ag nanoparticle array, but
with 34, 55, and 72 nm nanoparticles, respectively. Absorp-
tion data are displayed both before and after a 30 min incu-
bation of the sensor platform with a 1.0 M streptavidin
solution. This concentration should be more than enough to
cause saturation binding under the conditions employed. As
can be seen, protein binding caused a redshift in the plasmon
resonance frequency for all three diameters of Ag nanopar-
ticles. However, the magnitude of the red shift, 	max, was
clearly size dependent. Speciﬁcally, a very distinct decrease
in 	max was observed with increasing metal particle size.
This is consistent with the notion that the resonant electric
ﬁeld falls off faster with distance from the surface for smaller
particles.61 Hence, these nanoparticles are more sensitive to
changes in refractive index within the ﬁrst few nanometers of
the surface. The values of 	max as a function of size are
provided in Table I. As can be seen, the shift is nearly same
for the 19 and 34 nm arrays. The shift, however, drops dra-
matically as the size increased further, suggesting that larger
particles become increasingly less useful as T-LSPR sensors.
This was the case in spite of the fact that the absorption
increased with the size of the nanoparticles Table I. There-
FIG. 3. UV/visible spectra of 19 nm diameter Ag nanoparticle biosensor
array a before and after incubated with b 10−12 M and c 10−6 M
streptavidin solutions, respectively.
FIG. 4. Binding curve of the biotin-streptavidin interaction using a 19 nm
diameter Ag nanoparticle sensor array. The solid dots represent experimental
points while the curve represents the ﬁt to a Langmuir isotherm.
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fore, for practical sensor design, it appears that smaller nano-
particle sizes at least down to 20 or 30 nm appear to be
more useful than larger ones.
The current results are in reasonable arrangement with
previous studies by Nath and Chilkoti, where they found that
nanoparticles with 39 nm diameters had optimal sensitivity.
In that case, spherical Au nanoparticles were made in solu-
tion and subsequently loaded onto the substrate. Therefore,
our half sphere-shaped Ag nanoparticle array would not nec-
essarily be expected to yield identical results. Nevertheless,
the need to tune both the adsorption and frequency shift
probably lead to optimum performance in the range of a few
tens of nanometers for nanoparticles, in general.
IV. DISCUSSION
Ideal biosensors should be extremely sensitive, highly se-
lective, simple to fabricate, and easy to use. They should
operate with tiny sample volumes in a label-free fashion with
low background response. Surface plasmon resonance tech-
niques have, at least in principle, many of these features,
which would allow them to compare favorably with conven-
tional labeling techniques such as ﬂuorescence.56 Moreover,
T-LSPR should be easier to employ than reﬂectometry SPR
because of its very simple setup. The combination of trans-
mission mode detection, rapid metal nanoparticle fabrication,
and surface passivation with a PEG-thiol appear to make this
platform attractive.
It should be noted that Au and Ag nanoarchitectures are
common motifs for plasmonic-based biosensors. Among the
several T-LSPR experiments based on Au/Ag nanoparticles
reported previously, two general strategies were employed to
fabricate nanoparticle arrays on substrates. First, nanopar-
ticles can be made in solution using standard procedures and
loaded onto the substrate by speciﬁc linkage or nonspeciﬁc
adsorption.11,14 Alternatively, the nanoparticles can be di-
rectly fabricated in situ on the substrate.12,21,22,62 The ﬁrst
method requires an extra step and the ﬁnal surface coverage
can be difﬁcult to control. On the other hand, direct deposi-
tion can limit the variety of geometries of the particles and
uniformity may be uneven. The present method is advanta-
geous because it circumvents several of these problems. For
example, the use of a template allows signiﬁcant control over
particle size, spacing, and geometry while still providing the
convenience of a direct fabrication method. Indeed, the size
distribution of our particles is narrow and the fabrication
process can be performed rapidly.
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